Why We Are On The Cusp Of A Golden Age of Medicine

Written By Kathleen Otto

Panna Sharma is the President and CEO of Lantern Pharma, a clinical-stage oncology biotech using AI and genomics to innovate the rescue, revitalisation, and development of precision cancer therapeutics. Lu Rahman spoke to the man behind this biotech to find out why he believes AI is about to change the drug development landscape.

Kathleen Otto
Previous

How BioNTX Member NCTM Matched North TXs' Rapidly Growing Biotech and Biopharma Industries